Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series Ltd: World’s leading Event Organizer

Back

Thanos Mitrelias

Thanos Mitrelias

CEO
University of Cambridge
UK

Biography

Thanos Mitrelias is a director with 14 years of entrepreneurial and scientific activity. He has been the Founding CEO of two spin offs the University of Cambridge: Cavendish Nano Therapeutics aimed at offering advanced medical systems for the targeted eradication of cancer tumour and Cambridge Bio Magnetics established to commercialize a platform and disruptive technology to address needs in clinical diagnostics and the oil and gas industries. He is a frequent speaker and panelist in international business and scientific fore, such as the Horasis Global Business Conferences, where he usually speaks on knowledge based economy and entrepreneurship. He has been at the University of Cambridge since 1994, has several patent applications, has raised more than $5.5 million for numerous projects and has wide scientific and commercial expertise in biotechnology and Nano science. Mitrelias has also set up Academy Capital Partners, a management company that aims to raise a substantial venture capital fund aimed mainly at investments in early stage technology companies with proven market traction and innovative products. He is also actively engaged in activities in the Middle East aimed at transforming the region’s economy to a knowledge based economy. Dr Mitrelias is also currently involved in setting up various multi-million collaborative international projects with academic institutions in Peru and Brazil. He holds a PhD in Natural Sciences from the University of Cambridge, an MSc (Eng) in Materials Science awarded with Distinction from the University of Liverpool and a BSc in Physics from the University of Ioannina, Greece.

Research Interest

His main research interest is in the field of Biotechnology, Nano science, targeted eradication of cancer tumour and clinical diagnostics.